Gainers
22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of nicotine for smokers who use them.
Finch Therapeutics Group (NASDAQ:FNCH) reported quarterly losses of $(0.32) per share. This is a 68.63 percent increase over losses of $(1.02) per share from the same period last year. The company reported $2.83 million
Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (NASDAQ:FNCH), a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery® platform to develop a